These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8976820

  • 1. The potential role of amifostine (Ethyol) in haematological malignancies.
    Gorin NC.
    Eur J Cancer; 1996; 32A Suppl 4():S31-9. PubMed ID: 8976820
    [Abstract] [Full Text] [Related]

  • 2. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L, Hu C, Giarratana MC, Bouchet S, Conlon J, Capizzi RL, Gorin NC.
    Blood; 1995 Oct 01; 86(7):2849-55. PubMed ID: 7670119
    [Abstract] [Full Text] [Related]

  • 3. Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
    Douay L, Hu C, Giarratana MC, Gorin NC.
    Eur J Cancer; 1995 Oct 01; 31A Suppl 1():S14-6. PubMed ID: 7577094
    [Abstract] [Full Text] [Related]

  • 4. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
    Fauth F, Martin H, Sonnhoff S, Bialleck H, Wiesneth M, Mihanovic B, Hoelzer D.
    Bone Marrow Transplant; 2000 Apr 01; 25(8):831-6. PubMed ID: 10808203
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R, Grünebach F, Bader P, Vogel W, Kanz L, Brugger W, Scheding S.
    J Hematother Stem Cell Res; 2001 Dec 01; 10(6):777-85. PubMed ID: 11798504
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R, Bony V, Lopez M.
    Prog Clin Biol Res; 1994 Dec 01; 389():23-9. PubMed ID: 7700906
    [No Abstract] [Full Text] [Related]

  • 7. Use of amifostine in bone marrow purging.
    Cagnoni PJ, Jones RB, Bearman SI, Ross M, Hami L, Franklin WA, Capizzi R, Schein PS, Shpall EJ.
    Semin Oncol; 1996 Aug 01; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [Abstract] [Full Text] [Related]

  • 8. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
    Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC, McCulloch W.
    Blood; 1994 Jun 01; 83(11):3132-7. PubMed ID: 8193351
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V, Kabral A, Bradstock KF.
    Bone Marrow Transplant; 1991 Nov 01; 8(5):351-5. PubMed ID: 1768969
    [Abstract] [Full Text] [Related]

  • 11. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP, Rogers PC, Chan KW, Rodriguez WC.
    Prog Clin Biol Res; 1992 Nov 01; 377():57-62. PubMed ID: 1332075
    [No Abstract] [Full Text] [Related]

  • 12. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec 01; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 13. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC, Labopin M, Laporte JP, Douay L, Lopez M, Lesage S, Fouillard L, Isnard F, Jouet JP, Bellal N, Perot C, Van Den Akker J, Bauters F, Najman A.
    Exp Hematol; 1999 Dec 01; 27(12):1822-30. PubMed ID: 10641600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants.
    Douay L, Hu C, Giarratana MC, Gorin NC.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 11):16-20. PubMed ID: 7973773
    [Abstract] [Full Text] [Related]

  • 16. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar 01; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 17. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
    Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B.
    Leukemia; 1991 Oct 01; 5(10):896-904. PubMed ID: 1835746
    [Abstract] [Full Text] [Related]

  • 18. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B, Makrynikola V, Bradstock K.
    Prog Clin Biol Res; 1992 Oct 01; 377():41-7. PubMed ID: 1438438
    [No Abstract] [Full Text] [Related]

  • 19. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.
    Capizzi RL, Scheffler BJ, Schein PS.
    Cancer; 1993 Dec 01; 72(11 Suppl):3495-501. PubMed ID: 8242582
    [Abstract] [Full Text] [Related]

  • 20. Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery.
    Poloni A, Leoni P, Curzi L, Cantori I, Mancini S, Montanari M, Masia MC, Olivieri A.
    Exp Hematol; 1999 Oct 01; 27(10):1548-56. PubMed ID: 10517497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.